Global Tuberculosis Diagnostic Market Size, Status and Forecast 2020-2026

1 Report Overview

• 1.1 Study Scope
• 1.2 Key Market Segments
• 1.3 Players Covered: Ranking by Tuberculosis Diagnostic Revenue
• 1.4 Market by Type
  • 1.4.1 Global Tuberculosis Diagnostic Market Size Growth Rate by Type: 2020 VS 2026
  • 1.4.2 Radiographic Method
  • 1.4.3 Diagnostic Laboratory Methods
  • 1.4.4 Nucleic Acid Testing
  • 1.4.5 Phage Assay
  • 1.4.6 Detection of Latent Infection
  • 1.4.7 Cytokine Detection Assay
  • 1.4.8 Detection of Drug Resistance
• 1.5 Market by Application
  • 1.5.1 Global Tuberculosis Diagnostic Market Share by Application: 2020 VS 2026
  • 1.5.2 Infants
  • 1.5.3 Adults
• 1.6 Study Objectives
• 1.7 Years Considered

2 Global Growth Trends

• 2.1 Global Tuberculosis Diagnostic Market Perspective (2015-2026)
• 2.2 Global Tuberculosis Diagnostic Growth Trends by Regions
  • 2.2.1 Tuberculosis Diagnostic Market Size by Regions: 2015 VS 2020 VS 2026
  • 2.2.2 Tuberculosis Diagnostic Historic Market Share by Regions (2015-2020)
  • 2.2.3 Tuberculosis Diagnostic Forecasted Market Size by Regions (2021-2026)
• 2.3 Industry Trends and Growth Strategy
  • 2.3.1 Market Top Trends
  • 2.3.2 Market Drivers
  • 2.3.3 Market Challenges
  • 2.3.4 Porter’s Five Forces Analysis
  • 2.3.5 Tuberculosis Diagnostic Market Growth Strategy
  • 2.3.6 Primary Interviews with Key Tuberculosis Diagnostic Players (Opinion Leaders)

3 Competition Landscape by Key Players

• 3.1 Global Top Tuberculosis Diagnostic Players by Market Size
  • 3.1.1 Global Top Tuberculosis Diagnostic Players by Revenue (2015-2020)
  • 3.1.2 Global Tuberculosis Diagnostic Revenue Market Share by Players (2015-2020)
  • 3.1.3 Global Tuberculosis Diagnostic Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
• 3.2 Global Tuberculosis Diagnostic Market Concentration Ratio
  • 3.2.1 Global Tuberculosis Diagnostic Market Concentration Ratio (CR5 and HHI)
  • 3.2.2 Global Top 10 and Top 5 Companies by Tuberculosis Diagnostic Revenue in 2019
• 3.3 Tuberculosis Diagnostic Key Players Head office and Area Served
• 3.4 Key Players Tuberculosis Diagnostic Product Solution and Service
• 3.5 Date of Enter into Tuberculosis Diagnostic Market
• 3.6 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)

• 4.1 Global Tuberculosis Diagnostic Historic Market Size by Type (2015-2020)
• 4.2 Global Tuberculosis Diagnostic Forecasted Market Size by Type (2021-2026)

5 Market Size by Application (2015-2026)

• 5.1 Global Tuberculosis Diagnostic Market Size by Application (2015-2020)
• 5.2 Global Tuberculosis Diagnostic Forecasted Market Size by Application (2021-2026)

6 North America

• 6.1 North America Tuberculosis Diagnostic Market Size (2015-2020)
• 6.2 Tuberculosis Diagnostic Key Players in North America (2019-2020)
• 6.3 North America Tuberculosis Diagnostic Market Size by Type (2015-2020)
• 6.4 North America Tuberculosis Diagnostic Market Size by Application (2015-2020)

7 Europe

• 7.1 Europe Tuberculosis Diagnostic Market Size (2015-2020)
• 7.2 Tuberculosis Diagnostic Key Players in Europe (2019-2020)
• 7.3 Europe Tuberculosis Diagnostic Market Size by Type (2015-2020)
• 7.4 Europe Tuberculosis Diagnostic Market Size by Application (2015-2020)

8 China

• 8.1 China Tuberculosis Diagnostic Market Size (2015-2020)
• 8.2 Tuberculosis Diagnostic Key Players in China (2019-2020)
• 8.3 China Tuberculosis Diagnostic Market Size by Type (2015-2020)
• 8.4 China Tuberculosis Diagnostic Market Size by Application (2015-2020)

9 Japan

• 9.1 Japan Tuberculosis Diagnostic Market Size (2015-2020)
• 9.2 Tuberculosis Diagnostic Key Players in Japan (2019-2020)
• 9.3 Japan Tuberculosis Diagnostic Market Size by Type (2015-2020)
• 9.4 Japan Tuberculosis Diagnostic Market Size by Application (2015-2020)

10 Southeast Asia

• 10.1 Southeast Asia Tuberculosis Diagnostic Market Size (2015-2020)
• 10.2 Tuberculosis Diagnostic Key Players in Southeast Asia (2019-2020)
• 10.3 Southeast Asia Tuberculosis Diagnostic Market Size by Type (2015-2020)
• 10.4 Southeast Asia Tuberculosis Diagnostic Market Size by Application (2015-2020)

11 India

• 11.1 India Tuberculosis Diagnostic Market Size (2015-2020)
• 11.2 Tuberculosis Diagnostic Key Players in India (2019-2020)
• 11.3 India Tuberculosis Diagnostic Market Size by Type (2015-2020)
• 11.4 India Tuberculosis Diagnostic Market Size by Application (2015-2020)

12 Central & South America

• 12.1 Central & South America Tuberculosis Diagnostic Market Size (2015-2020)
• 12.2 Tuberculosis Diagnostic Key Players in Central & South America (2019-2020)
• 12.3 Central & South America Tuberculosis Diagnostic Market Size by Type (2015-2020)
• 12.4 Central & South America Tuberculosis Diagnostic Market Size by Application (2015-2020)

13 Key Players Profiles

• 13.1 Thermo Fisher Scientific
  • 13.1.1 Thermo Fisher Scientific Company Details
  • 13.1.2 Thermo Fisher Scientific Business Overview
  • 13.1.3 Thermo Fisher Scientific Tuberculosis Diagnostic Introduction
  • 13.1.4 Thermo Fisher Scientific Revenue in Tuberculosis Diagnostic Business (2015-2020))
  • 13.1.5 Thermo Fisher Scientific Recent Development
• 13.2 Hologic Corporation
  • 13.2.1 Hologic Corporation Company Details
  • 13.2.2 Hologic Corporation Business Overview
  • 13.2.3 Hologic Corporation Tuberculosis Diagnostic Introduction
  • 13.2.4 Hologic Corporation Revenue in Tuberculosis Diagnostic Business (2015-2020)
  • 13.2.5 Hologic Corporation Recent Development
• 13.3 Abbott Laboratories
  • 13.3.1 Abbott Laboratories Company Details
  • 13.3.2 Abbott Laboratories Business Overview
  • 13.3.3 Abbott Laboratories Tuberculosis Diagnostic Introduction
  • 13.3.4 Abbott Laboratories Revenue in Tuberculosis Diagnostic Business (2015-2020)
  • 13.3.5 Abbott Laboratories Recent Development
• 13.4 Abbott
  • 13.4.1 Abbott Company Details
  • 13.4.2 Abbott Business Overview
  • 13.4.3 Abbott Tuberculosis Diagnostic Introduction
  • 13.4.4 Abbott Revenue in Tuberculosis Diagnostic Business (2015-2020)
  • 13.4.5 Abbott Recent Development
• 13.5 Becton
  • 13.5.1 Becton Company Details
  • 13.5.2 Becton Business Overview
  • 13.5.3 Becton Tuberculosis Diagnostic Introduction
  • 13.5.4 Becton Revenue in Tuberculosis Diagnostic Business (2015-2020)
  • 13.5.5 Becton Recent Development
• 13.6 Dickinson and Company
  • 13.6.1 Dickinson and Company Company Details
  • 13.6.2 Dickinson and Company Business Overview
  • 13.6.3 Dickinson and Company Tuberculosis Diagnostic Introduction
  • 13.6.4 Dickinson and Company Revenue in Tuberculosis Diagnostic Business (2015-2020)
  • 13.6.5 Dickinson and Company Recent Development
• 13.7 F. Hoffmann-La Roche
  • 13.7.1 F. Hoffmann-La Roche Company Details
  • 13.7.2 F. Hoffmann-La Roche Business Overview
  • 13.7.3 F. Hoffmann-La Roche Tuberculosis Diagnostic Introduction
  • 13.7.4 F. Hoffmann-La Roche Revenue in Tuberculosis Diagnostic Business (2015-2020)
  • 13.7.5 F. Hoffmann-La Roche Recent Development
• 13.8 bioMerieux
  • 13.8.1 bioMerieux Company Details
  • 13.8.2 bioMerieux Business Overview
  • 13.8.3 bioMerieux Tuberculosis Diagnostic Introduction
  • 13.8.4 bioMerieux Revenue in Tuberculosis Diagnostic Business (2015-2020)
  • 13.8.5 bioMerieux Recent Development
• 13.9 Sanofi
  • 13.9.1 Sanofi Company Details
  • 13.9.2 Sanofi Business Overview
  • 13.9.3 Sanofi Tuberculosis Diagnostic Introduction
  • 13.9.4 Sanofi Revenue in Tuberculosis Diagnostic Business (2015-2020)
  • 13.9.5 Sanofi Recent Development
• 13.10 Cepheid
  • 13.10.1 Cepheid Company Details
  • 13.10.2 Cepheid Business Overview
  • 13.10.3 Cepheid Tuberculosis Diagnostic Introduction
  • 13.10.4 Cepheid Revenue in Tuberculosis Diagnostic Business (2015-2020)
  • 13.10.5 Cepheid Recent Development
• 13.11 Hain Lifescience
  • 10.11.1 Hain Lifescience Company Details
  • 10.11.2 Hain Lifescience Business Overview
  • 10.11.3 Hain Lifescience Tuberculosis Diagnostic Introduction
  • 10.11.4 Hain Lifescience Revenue in Tuberculosis Diagnostic Business (2015-2020)
  • 10.11.5 Hain Lifescience Recent Development
• 13.12 QIAGEN
  • 10.12.1 QIAGEN Company Details
  • 10.12.2 QIAGEN Business Overview
  • 10.12.3 QIAGEN Tuberculosis Diagnostic Introduction
  • 10.12.4 QIAGEN Revenue in Tuberculosis Diagnostic Business (2015-2020)
  • 10.12.5 QIAGEN Recent Development

14 Analyst's Viewpoints/Conclusions

15 Appendix

• 15.1 Research Methodology
  • 15.1.1 Methodology/Research Approach
  • 15.1.2 Data Source
• 15.2 Disclaimer